Morbidity of breast cancer, and death rate from it in Tashkent during 2012–2022
https://doi.org/10.17650/1994-4098-2024-20-4-52-61
Abstract
Background. In the developed countries breast cancer (BC) is the most frequent form of localization of malignant neoplasms at women.
Aim. The analysis of BC morbidity and death rates from it in Tashkent for 2012–2022 in intensive (IR) and standardized rates (SR) in the international standard of World Health Organization.
Materials and methods. Data of cancer-register which is functioning at organizational-statistical department of the Tashkent City Branch of the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology, Ministry of Health of the Republic of Uzbekistan were studied. The IR and SR of morbidity of BC and death rates from it in Tashkent are calculated.
Results. The female morbidity by malignant neoplasms (in IR) in Tashkent city gradually growth during 2012–2022, and it some decreases in 2020. SR in 2020 (the basic year of pandemic COVID-19) there was “splash” in 2020 morbidity by malignant neoplasms, in particular, BC, and SR of death rate from them among the female population of Tashkent in comparison with other years of this period. This occurred at the expense of increase of their frequencies (mainly) in women aged 45–64 years and older.
Conclusion. Detected facts are connected with practice of diagnostics and treatment of BC on the basis of spontaneous reference to a doctor of the population (generated in Uzbekistan for the last decades) and by absence of regular practice of early diagnostics Bс (screening). These facts are important for further development of system of control of BC in Tashkent.
About the Authors
M. D. Dzhuraev
Republican Specialized Scientific-Practical Medical Center of Oncology and Radiology, Ministry of Health of the Republic of Uzbekistan
Uzbekistan
Uzbekistan
383 Farobi St., Tashkent 100179, Republic of Uzbekistan
F. M. Dzhuraev
Tashkent Medical Park by Urologic Complex
Uzbekistan
Uzbekistan
Farrukh Mirzhalolovich Dzhuraev
7 Maksuda Sheikh-Zade St., Tashkent 1001237, Republic of Uzbekistan
A. B. Kutlumuratov
Department of Oncology, Samarkand State Medical Institute
Uzbekistan
Uzbekistan
18 Amira Temura St., Samarkand 100400, Republic of Uzbekistan
D. Zholgasova
Department of Medical Statistics, Tashkent City Branch of the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology, Ministry of Health of the Republic of Uzbekistan
Uzbekistan
Uzbekistan
171 Tursunkulova St., Proezd Bogiston, Tashkent 100054, Republic of Uzbekistan
References
1. McGuire A., Brown J.A., Malone C. et al. Effects of age on the detection and management of breast cancer. Cancers 2015;7(2):908–29.
2. World Cancer Report. WHO, 2014. Ch. 1.1.
3. Breast Cancer: Prevention and Control. WHO, 2015. Available at: https://web.archive.Org/web/20150906121739/http://www.who-int/cancer/detection/breastcancer/en/indexl.html.
4. World Cancer Report. IARC, 2008. Available at: http://www.iarc.fr/en/publications/pdfs-online/wcr/2008/wcr_2008.pdf.
5. Bray F., Ferlay J., Soerjomataram I. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. J Cancer Clin 2018;68(6):394–424.
6. Male Breast Cancer Treatment. NCI, 2014. Available at: http://www.cancer.gov/cancertopics/pdq/treatment/malebreast/HealthProfessional.
7. Malignant tumors in Russia in 2020 (morbidity and mortality). Eds.: А.D. Kaprin, V.V. Starinskiy, A.O. Shakhzadova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2021. 252 p. (In Russ.).
8. Olopade O.L, Falkson C.I. Breast Cancer in Women of African Descent. Springer Science & Business Media, 2010. P. 5.
9. Resolutions of the President of the Republic of Uzbekistan. No. PP-2866 dated 04.04.2017, No. PP-5130 dated 27.05.2021 “On measures for the further development of the oncology service and improvement of oncology care for the population of the Republic of Uzbekistan”. (In Russ.).
10. Doll R., Peto R. The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today. JNCI 1981;66(6):1191–308.
11. Kirkwood В.R., Sterne J.A.S. Essential Medical Statistics. 2nd edn. Oxford, 2003. 512 p.
12. Lakin G.F. Biometrics: Textbook for biological specialization of higher education institutions. 4th edn. Moscow: Vysshaya Shkola, 1990. 352 p. (In Russ.).
13. Merabishvili V.M. Oncological statistics (traditional methods, new information technologies): Guide for doctors. 2nd edn. Part I. Saint Petersburg, 2015. 223 p. (In Russ.).
14. Galanopoulos M., Gkeros F., Doukatas A. et al. COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract. World J Gastroenterol 2020;26(31):4579–88. DOI: 10.3748/wjg.v26.i31.4579
15. Mariotto A.B., Feuer E.J., Howlader N. et al. Interpreting cancer incidence trends: Challenges due to the COVID-19 pandemic. JNCI 2023;115(9):1109–11. DOI: 10.1093/jnci/djad086
Review
For citations:
Dzhuraev M.D., Dzhuraev F.M., Kutlumuratov A.B., Zholgasova D. Morbidity of breast cancer, and death rate from it in Tashkent during 2012–2022. Tumors of female reproductive system. 2024;20(4):52-61. (In Russ.) https://doi.org/10.17650/1994-4098-2024-20-4-52-61
Views:
78
Email this article 